DK1835923T3 - Skemaer til intra-artikulær visco-supplering - Google Patents

Skemaer til intra-artikulær visco-supplering

Info

Publication number
DK1835923T3
DK1835923T3 DK05855034.4T DK05855034T DK1835923T3 DK 1835923 T3 DK1835923 T3 DK 1835923T3 DK 05855034 T DK05855034 T DK 05855034T DK 1835923 T3 DK1835923 T3 DK 1835923T3
Authority
DK
Denmark
Prior art keywords
articular
intra
schemes
visco
supplement
Prior art date
Application number
DK05855034.4T
Other languages
English (en)
Inventor
Francois Bailleul
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36633154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1835923(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of DK1835923T3 publication Critical patent/DK1835923T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
DK05855034.4T 2004-12-30 2005-12-20 Skemaer til intra-artikulær visco-supplering DK1835923T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64074904P 2004-12-30 2004-12-30
PCT/US2005/046409 WO2006073835A2 (en) 2004-12-30 2005-12-20 Regiments for intra-articular viscosupplementation

Publications (1)

Publication Number Publication Date
DK1835923T3 true DK1835923T3 (da) 2013-10-21

Family

ID=36633154

Family Applications (2)

Application Number Title Priority Date Filing Date
DK13180465.0T DK2664334T3 (da) 2004-12-30 2005-12-20 Regimer til intra-artikulær viscosupplementering
DK05855034.4T DK1835923T3 (da) 2004-12-30 2005-12-20 Skemaer til intra-artikulær visco-supplering

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK13180465.0T DK2664334T3 (da) 2004-12-30 2005-12-20 Regimer til intra-artikulær viscosupplementering

Country Status (16)

Country Link
US (4) US7931030B2 (da)
EP (5) EP1835923B1 (da)
JP (4) JP5725594B2 (da)
KR (3) KR20140041926A (da)
CN (4) CN101094680A (da)
AU (1) AU2005323095B2 (da)
BR (1) BRPI0518542A2 (da)
CA (2) CA2744999A1 (da)
DK (2) DK2664334T3 (da)
ES (2) ES2537751T3 (da)
HU (1) HUE025255T2 (da)
IL (1) IL183581A (da)
PL (2) PL1835923T3 (da)
PT (2) PT2664334E (da)
SI (2) SI1835923T1 (da)
WO (1) WO2006073835A2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
KR20140041926A (ko) * 2004-12-30 2014-04-04 젠자임 코포레이션 관절내 관절액보충요법을 위한 치료 방법
US20070196342A1 (en) * 2005-12-14 2007-08-23 Sadozai Khalid K Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
CA2633957A1 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP1968499A1 (en) * 2005-12-14 2008-09-17 Anika Therapeutics Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
CA2672002C (en) 2006-12-06 2015-06-02 Seikagaku Corporation Cross-linked hyaluronic acid having long-lasting effect of treating arthritic disorders
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
EP2324064B1 (en) 2008-09-02 2017-11-08 Tautona Group LP Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
AU2010269150B2 (en) * 2009-07-10 2016-11-03 Medicaltree Patent Ltd Implantable medical device for lubrication of a synovial joint and method for implanting the device
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
WO2012026468A1 (ja) 2010-08-23 2012-03-01 電気化学工業株式会社 架橋ヒアルロン酸組成物及び自己架橋ヒアルロン酸粒子
JP2013542837A (ja) 2010-11-15 2013-11-28 ジンマー オーソバイオロジクス，インコーポレイティド 骨空隙充填剤
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
PT3019177T (pt) * 2013-07-10 2020-12-30 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
KR101582380B1 (ko) * 2013-09-11 2016-01-05 주식회사 제네웰 손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
WO2015142781A1 (en) * 2014-03-21 2015-09-24 Rmg, Inc. Mobile based exercise and rehabilitation
GB201408752D0 (en) * 2014-05-16 2014-07-02 Stemmatters Biotecnologia E Medicina Regenerativa Sa Arthritis treatment
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
WO2016034745A2 (en) * 2015-09-22 2016-03-10 Cylenchar Limited A method for concentrating and/or entrapping radioisotopes from an aqueous solution
EP3842047A1 (en) 2015-09-24 2021-06-30 Matrix Biology Institute High elasticity hyaluronan compositions and methods of use thereof
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
CN111868528A (zh) * 2018-04-03 2020-10-30 赛诺菲 侧向流动免疫测定条状装置
WO2022051060A1 (en) * 2020-09-01 2022-03-10 Orthogenrx, Inc. Crosslinking of non-animal-derived hyaluronic acid with divinyl sulfone

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4636524A (en) * 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US5099013A (en) 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US5246698A (en) 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5143724A (en) 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2061566C (en) * 1992-02-20 2002-07-09 Rudolf E. Falk Treatment of disease employing hyaluronic acid and nsaids
US5219360A (en) * 1991-05-10 1993-06-15 Fortis Research Corporation Mammary prosthesis fill and method of making same
US5143351A (en) * 1991-08-29 1992-09-01 Pierce Daniel H Self-locking valve spring retainer
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
AU722250B2 (en) * 1995-11-15 2000-07-27 Seikagaku Corporation Photocured crosslinked-hyaluronic acid gel and method of preparation thereof
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
AU724960C (en) * 1996-02-09 2002-08-15 Swedish Orphan Biovitrum Ab (Publ) Composition comprising interleukin-1 inhibitor and controlled release polymer
JP3521378B2 (ja) * 1996-08-13 2004-04-19 コニカミノルタホールディングス株式会社 両面複写装置
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
DE69822285T2 (de) * 1998-02-27 2005-01-27 Stichting Hyppomedics Verfahren zur Herstellung von vernetzter Hyaluronsäure
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
AU774977B2 (en) 1998-11-10 2004-07-15 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for the preparation thereof and medical materials containing the same
US6677321B1 (en) * 1999-12-09 2004-01-13 Bruce Levin Methods and compositions for treatment of inflammatory disease
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US6527760B1 (en) * 2000-09-25 2003-03-04 Vijay B. Vad Out-patient joint lavage kit and protocol
DE60117502T2 (de) * 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material
US7119062B1 (en) * 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20030008817A1 (en) * 2001-07-03 2003-01-09 Tom Sander Cross-link reversing agent
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
CA2477391A1 (en) * 2002-03-01 2003-09-12 Denis Schrier Method of treating osteoarthritis
US20030232784A1 (en) * 2002-06-14 2003-12-18 Benedict James J. Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
JP4383035B2 (ja) * 2002-10-29 2009-12-16 電気化学工業株式会社 ヒアルロン酸ゲル及びその製造方法
ATE448323T1 (de) * 2003-03-05 2009-11-15 Halozyme Inc Lösliches hyaluronidase-glycoprotein (shasegp), verfahren zu seiner herstellung, verwendungen und dieses enthaltende pharmazeutische zusammensetzungen
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
DK1677806T3 (da) * 2003-10-09 2009-02-23 Robert John Petrella Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
CN100537606C (zh) * 2003-12-30 2009-09-09 建新公司 源自交联的透明质酸和/或hylan的粘性凝胶、其制备和用途
WO2006012492A2 (en) * 2004-07-23 2006-02-02 Mucosal Therapeutics Llc Compositions and methods for viscosupplementation
BRPI0515191A (pt) * 2004-08-13 2008-07-08 Angiotech Internac Ag composição farmacêutica, método para aumentar osso ou substituir perda óssea, método para reduzir a dor associada com cicatriz pós-cirúrgica, método para prevenir aderência cirúrgicas, método para aumento ou reparo de pele ou tecido, método para manter volume em fluido ocular durante cirurgia ocular, método para reduzir a dor associada com osteoartrite, método para tratar doença de refluxo gastroesofágico, método para tratar ou prevenir incontinência urinária, método para tratar ou prevenir incontinência fecal, implante método e dispositivo médico
KR20140041926A (ko) 2004-12-30 2014-04-04 젠자임 코포레이션 관절내 관절액보충요법을 위한 치료 방법
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

Also Published As

Publication number Publication date
WO2006073835A2 (en) 2006-07-13
HUE025255T2 (en) 2016-03-29
KR20140041926A (ko) 2014-04-04
US7931030B2 (en) 2011-04-26
PT1835923E (pt) 2013-11-04
ES2537751T3 (es) 2015-06-11
CN104689460A (zh) 2015-06-10
US20130197444A1 (en) 2013-08-01
BRPI0518542A2 (pt) 2008-11-25
CA2744999A1 (en) 2006-07-13
JP2013035860A (ja) 2013-02-21
CA2590159C (en) 2011-07-12
JP2016128469A (ja) 2016-07-14
EP2289523A2 (en) 2011-03-02
JP5725594B2 (ja) 2015-05-27
CN102416020A (zh) 2012-04-18
SI1835923T1 (sl) 2014-01-31
EP2664336A2 (en) 2013-11-20
WO2006073835A3 (en) 2006-10-05
KR20150052326A (ko) 2015-05-13
CN101094680A (zh) 2007-12-26
PL2664334T3 (pl) 2015-08-31
EP1835923A2 (en) 2007-09-26
JP6139716B2 (ja) 2017-05-31
CN104689460B (zh) 2018-03-13
PL1835923T3 (pl) 2014-03-31
JP2008526747A (ja) 2008-07-24
US20060148755A1 (en) 2006-07-06
EP2664334A1 (en) 2013-11-20
JP2015007077A (ja) 2015-01-15
KR101808800B1 (ko) 2018-01-18
DK2664334T3 (da) 2015-03-23
AU2005323095B2 (en) 2011-12-15
KR20070104579A (ko) 2007-10-26
ES2436179T3 (es) 2013-12-27
IL183581A0 (en) 2007-10-31
CN103860582A (zh) 2014-06-18
CA2590159A1 (en) 2006-07-13
PT2664334E (pt) 2015-04-23
EP1835923B1 (en) 2013-10-09
IL183581A (en) 2016-10-31
US20110183936A1 (en) 2011-07-28
SI2664334T1 (sl) 2015-06-30
EP2664335A2 (en) 2013-11-20
EP2289523A3 (en) 2011-09-28
EP2664335A3 (en) 2015-12-16
EP2664334B1 (en) 2015-03-04
AU2005323095A1 (en) 2006-07-13
EP2664336A3 (en) 2015-12-16
US20120258931A1 (en) 2012-10-11

Similar Documents

Publication Publication Date Title
DK1835923T3 (da) Skemaer til intra-artikulær visco-supplering
CY2016009I1 (el) Ενωσεις για την αναστολη του ενζυμου πρωτεασωματος
DE502005010058D1 (de) Entschäumerzusammensetzungen
DK1928521T3 (da) Trombektomikateterindsættelsessystem
ATE469145T1 (de) 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
DE502006001774D1 (de) Entschäumerformulierungen
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
DE502006001254D1 (de) Entschäumerzusammensetzungen
DE502005010242D1 (de) Entschäumerzusammensetzungen
DE602005003874D1 (de) Steckverbinder
DE602007001681D1 (de) 1,3-dioxan-carboxylsäuren
DE602004011999D1 (de) Mehrbenutzer-übertragungssystem
ITTO20040849A1 (it) Tubazione per carburante.
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
ITTO20060540A1 (it) Mensola di supporto per elementi edili aggettanti.
ITMO20050297A1 (it) Apparato di supporto
FI6455U1 (fi) Virtuaali-ikkunajärjestelmä
ITRM20050119A1 (it) Impianto di alimentazione di carburante.
ITRM20050118A1 (it) Impianto di alimentazione di carburante.
DE102004029701B8 (de) Steckverbinder
ITTV20050118A1 (it) Struttura di espositore, particolarmente per cucine
ITPD20040243A1 (it) Inserto per sottotacchi.
ITPG20040006A1 (it) Espositore per snak
FI20045050A0 (fi) Siirtopöytäjärjestelmä hyllystöhissiä varten
ITPN20030055A1 (it) Pannelli per mobili